- Home
- OSRH vs SNES Comparison
OSRH vs SNES Comparison
Compare OSRH & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSRH | SNES |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 14.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | OSRH | SNES |
|---|---|---|
| Price | $0.65 | $2.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 10.2M | 52.0K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,301,000.00 |
| Revenue This Year | N/A | $41.52 |
| Revenue Next Year | N/A | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 39.37 |
| 52 Week Low | $0.45 | $1.30 |
| 52 Week High | $12.54 | $6.24 |
Technical Indicators
Market Signals| Indicator | OSRH | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 38.59 |
| Support Level | $0.63 | $2.70 |
| Resistance Level | $0.77 | $2.94 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 12.16 | 9.80 |
Price Performance
Historical ComparisonAbout OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.